Holen Sie sich die Stockscreener-App
8.33
1.42%
-0.12
Handel nachbörslich:
8.33
4 D Molecular Therapeutics Inc Aktie (FDMT) Neueste Nachrichten
FDMT: Rapid phase 3 progress and strong market interest position 4D-150 for global commercialization - TradingView
FDMT: 4D-150 shows strong efficacy and safety, with global phase III trials advancing ahead of schedule - TradingView
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
FDMT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Where is 4D Molecular Therapeutics (FDMT) Headed According to the Street? - Yahoo Finance
FDMT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
4D Molecular Therapeutics (NASDAQ:FDMT) Stock Price Up 6.2%Time to Buy? - MarketBeat
Key Catalysts on the Horizon for 4D Molecular Therapeutics - AD HOC NEWS
4D Molecular Therapeutics (FDMT) to Release Quarterly Earnings on Friday - Defense World
4DMT to Participate in Upcoming Investor Conferences - GlobeNewswire
BVF group discloses 9.99% 4D Molecular stake (NASDAQ: FDMT) - Stock Titan
4DMT Announces New Employment Inducement Grants - The Manila Times
Biotech 4DMT hands 124,200 stock units to just nine recruits - Stock Titan
4D Molecular Therapeutics Advances Toward Phase 3 Milestones in Retina Gene Therapy - AD HOC NEWS
Barclays flags M&A tailwinds and pricing relief as upside catalysts for 4D Molecular Therapeutics, Inc. (FDMT) - MSN
Will 4D Molecular Therapeutics Inc. stock attract ESG investorsJuly 2025 Analyst Calls & Expert Verified Stock Movement Alerts - mfd.ru
Will 4D Molecular Therapeutics Inc. benefit from geopolitical trends2025 Institutional Moves & Smart Allocation Stock Reports - mfd.ru
What are analysts’ price targets for 4D Molecular Therapeutics Inc.2025 Support & Resistance & Entry Point Strategy Guides - mfd.ru
4D Molecular (FDMT) Completes Enrollment for Key Phase 3 Wet AMD Trial - GuruFocus
What is 4D Molecular Therapeutics Inc. s debt to equity ratioEarnings Recap Summary & Reliable Price Breakout Alerts - mfd.ru
4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD - Yahoo Finance
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Barclays Flags M&A Tailwinds and Pricing Relief as Upside Catalysts for 4D Molecular Therapeutics, Inc. (FDMT) - Finviz
Barclays Initiates Coverage of 4D Molecular Therapeutics (FDMT) with Overweight Recommendation - Nasdaq
Deep Dive Into 4D Molecular Therapeutics Stock: Analyst Perspectives (5 Ratings) - Benzinga
4D Molecular Therapeutics Restructures Equity via Warrant Exchange - TipRanks
4D Molecular Therapeutics: A Valuation Disconnect Amidst Clinical Progress - AD HOC NEWS
4D Molecular (FDMT) Grants RSUs to New Employees - GuruFocus
4D Molecular Therapeutics Grants 23,600 RSUs to New Employees - Intellectia AI
Biotech 4DMT hands 23,600 stock units to four new hires under award plan - Stock Titan
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Short Interest Update - MarketBeat
FDMT: 4D-150 gene therapy shows strong safety, efficacy, and commercial potential in retinal disease - TradingView
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Is 4D Molecular Therapeutics Inc. stock ready for breakoutJuly 2025 Intraday Action & Fast Moving Stock Trade Plans - ulpravda.ru
Is 4D Molecular Therapeutics Inc. stock a buy on dipsJuly 2025 Setups & Free Long-Term Investment Growth Plans - Улправда
Why 4D Molecular Therapeutics Inc. stock appeals to dividend seekersMarket Weekly Review & Low Drawdown Investment Strategies - Улправда
Stock Report: Can 4D Molecular Therapeutics Inc. stock double in next 5 years2025 Analyst Calls & Daily Technical Stock Forecast Reports - ulpravda.ru
Smart Money: Is 4D Molecular Therapeutics Inc. stock a safe investment in uncertain marketsJuly 2025 Trade Ideas & Free Reliable Trade Execution Plans - Улправда
Will 4D Molecular Therapeutics Inc. stock gain from strong economyJuly 2025 Outlook & High Return Stock Watch Alerts - ulpravda.ru
Can 4D Molecular Therapeutics Inc. stock double in next 5 yearsJuly 2025 Institutional & Risk Controlled Swing Alerts - Улправда
Is 4D Molecular Therapeutics Inc. stock a top momentum play2025 Volatility Report & High Accuracy Swing Trade Signals - Улправда
Los Angeles Daily News4D Molecular Therapeutics, Inc.Common Stock (Nasdaq:FDMT) Stock Quote - FinancialContent
4D Molecular Therapeutics, Inc. Announces Executive Changes - marketscreener.com
4DMT Provides Company Update and Anticipated Development Milestones for 2026 - The Manila Times
4D Molecular Therapeutics Announces Key Management Changes - TradingView — Track All Markets
4D Molecular Therapeutics expands phase 3 trial enrollment - MSN
Certain Restricted Stock Units of 4D Molecular Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 6-JAN-2026. - MarketScreener
Certain Options of 4D Molecular Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 6-JAN-2026. - marketscreener.com
Certain Common Stock of 4D Molecular Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 6-JAN-2026. - marketscreener.com
4D Molecular falls after early-stage trial data for cystic fibrosis therapy - MSN
Why Everyone Is Watching 4D Molecular Therapeutics, Inc. (FDMT) Closely - Finviz
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):